Search research articles
Contact Us
Filters
Showing results (21-30 of 296) with videos related to
Page
of 30
Sort By:
Expert Review of Clinical Immunology
|
March 17, 2020
Personalized medicine in rheumatic diseases: how close are we to being able to use genetic biomarkers to predict response to TNF inhibitors?
Megan Sutcliffe, Gemma Radley, Anne Barton
The Journal of Rheumatology
|
August 3, 2019
Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS
Meghna Jani, Hector Chinoy, Anne Barton, et al.
Bioinformatics (Oxford, England)
|
December 24, 2010
ASSIMILATOR: a new tool to inform selection of associated genetic variants for functional studies
Paul Martin, Anne Barton, Stephen Eyre
Modern Rheumatology
|
December 5, 2006
Genetic epidemiology of psoriatic arthritis
Pauline Ho, Anne Barton, Jane Worthington
Rheumatology (Oxford, England)
|
September 1, 2020
Predicting treatment response to IL6R blockers in rheumatoid arthritis
Bako Nouri, Nisha Nair, Anne Barton
Nature Reviews. Rheumatology
|
February 19, 2014
Genetic and epigenetic predictors of responsiveness to treatment in RA
Darren Plant, Anthony G Wilson, Anne Barton
Epigenomics
|
April 6, 2021
Cell-specific epigenetic drivers of pathogenesis in rheumatoid arthritis
Nisha Nair, Anne Barton, Anthony G Wilson
Clinical Therapeutics
|
August 10, 2023
Utility of Musculoskeletal Ultrasound in Psoriatic Arthritis
Ryan Malcolm Hum, Anne Barton, Pauline Ho
Pharmacogenomics
|
August 25, 2017
DNA methylation as a marker of response in rheumatoid arthritis
Nisha Nair, Anthony G Wilson, Anne Barton
Rheumatology (Oxford, England)
|
August 10, 2015
Identifying a novel locus for psoriatic arthritis
Ashley Budu-Aggrey, John Bowes, Anne Barton
Page
of 30
Search research articles
Search
Showing results (21-30 of 296) with videos related to
Sort By:
Page
of 30
Expert Review of Clinical Immunology
|
March 17, 2020
Personalized medicine in rheumatic diseases: how close are we to being able to use genetic biomarkers to predict response to TNF inhibitors?
Megan Sutcliffe, Gemma Radley, Anne Barton
The Journal of Rheumatology
|
August 3, 2019
Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS
Meghna Jani, Hector Chinoy, Anne Barton, et al.
Bioinformatics (Oxford, England)
|
December 24, 2010
ASSIMILATOR: a new tool to inform selection of associated genetic variants for functional studies
Paul Martin, Anne Barton, Stephen Eyre
Modern Rheumatology
|
December 5, 2006
Genetic epidemiology of psoriatic arthritis
Pauline Ho, Anne Barton, Jane Worthington
Rheumatology (Oxford, England)
|
September 1, 2020
Predicting treatment response to IL6R blockers in rheumatoid arthritis
Bako Nouri, Nisha Nair, Anne Barton
Nature Reviews. Rheumatology
|
February 19, 2014
Genetic and epigenetic predictors of responsiveness to treatment in RA
Darren Plant, Anthony G Wilson, Anne Barton
Epigenomics
|
April 6, 2021
Cell-specific epigenetic drivers of pathogenesis in rheumatoid arthritis
Nisha Nair, Anne Barton, Anthony G Wilson
Clinical Therapeutics
|
August 10, 2023
Utility of Musculoskeletal Ultrasound in Psoriatic Arthritis
Ryan Malcolm Hum, Anne Barton, Pauline Ho
Pharmacogenomics
|
August 25, 2017
DNA methylation as a marker of response in rheumatoid arthritis
Nisha Nair, Anthony G Wilson, Anne Barton
Rheumatology (Oxford, England)
|
August 10, 2015
Identifying a novel locus for psoriatic arthritis
Ashley Budu-Aggrey, John Bowes, Anne Barton
Page
of 30